Published in J Pharmacol Exp Ther on August 01, 2001
Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology (2002) 2.18
Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev (2014) 1.57
Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem (2009) 1.50
Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats. Inflammopharmacology (2012) 1.46
Autophagy and ethanol-induced liver injury. World J Gastroenterol (2009) 1.26
Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion. Alcohol Clin Exp Res (2002) 1.23
The maintenance of mitochondrial DNA integrity--critical analysis and update. Cold Spring Harb Perspect Biol (2013) 1.23
Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health (2010) 1.22
Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity. J Pharmacol Exp Ther (2005) 1.18
Is there more to aging than mitochondrial DNA and reactive oxygen species? FEBS J (2009) 1.14
Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol (2013) 1.04
Interleukin-6 is an important mediator for mitochondrial DNA repair after alcoholic liver injury in mice. Hepatology (2010) 1.04
Alcohol-induced autophagy contributes to loss in skeletal muscle mass. Autophagy (2014) 1.03
The awakening of an advanced malignant cancer: an insult to the mitochondrial genome. Biochim Biophys Acta (2011) 1.02
Oxidant-induced atrogin-1 and transforming growth factor-beta1 precede alcohol-related myopathy in rats. Muscle Nerve (2007) 1.02
Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol (2012) 1.00
Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury. Crit Care (2003) 0.97
Mitochondria and redox signaling in steatohepatitis. Antioxid Redox Signal (2011) 0.96
Nongenomic effects of estrogen mediate the dose-related myocardial oxidative stress and dysfunction caused by acute ethanol in female rats. Am J Physiol Endocrinol Metab (2013) 0.89
Ethanol withdrawal posttranslationally decreases the activity of cytochrome c oxidase in an estrogen reversible manner. Neurosci Lett (2007) 0.88
Role of central nervous system insulin resistance in fetal alcohol spectrum disorders. J Popul Ther Clin Pharmacol (2010) 0.88
Ethanol feeding enhances age-related deterioration of the rat hepatic mitochondrion. Am J Physiol Gastrointest Liver Physiol (2005) 0.86
Ethanol influences on Bax translocation, mitochondrial membrane potential, and reactive oxygen species generation are modulated by vitamin E and brain-derived neurotrophic factor. Alcohol Clin Exp Res (2011) 0.86
Constitutive mitochondrial DNA copy number in peripheral blood of melanoma families with and without CDKN2A mutations. J Carcinog Mutagen (2014) 0.81
Ethanol withdrawal provokes mitochondrial injury in an estrogen preventable manner. J Bioenerg Biomembr (2008) 0.80
Metabolic and environmental conditions determine nuclear genomic instability in budding yeast lacking mitochondrial DNA. G3 (Bethesda) (2014) 0.80
Ethanol withdrawal provokes opening of the mitochondrial membrane permeability transition pore in an estrogen-preventable manner. J Pharmacol Exp Ther (2008) 0.79
The "fast" and the "slow" modes of mitochondrial DNA degradation. Mitochondrial DNA (2014) 0.78
Alteration of Gene Expression, DNA Methylation, and Histone Methylation in Free Radical Scavenging Networks in Adult Mouse Hippocampus following Fetal Alcohol Exposure. PLoS One (2016) 0.77
Role of CYP2E1 in mitochondrial dysfunction and hepatic tissue injury in alcoholic and non-alcoholic diseases. Curr Mol Pharmacol (2015) 0.77
Integrating mRNA and miRNA Weighted Gene Co-Expression Networks with eQTLs in the Nucleus Accumbens of Subjects with Alcohol Dependence. PLoS One (2015) 0.77
Reactive Oxygen Species and Mitochondrial DNA Damage and Repair in BCR-ABL1 Cells Resistant to Imatinib. Biores Open Access (2015) 0.76
The cis and trans effects of the risk variants of coronary artery disease in the Chr9p21 region. BMC Med Genomics (2015) 0.75
Nutrition and Alcoholic Liver Disease: Effects of Alcoholism on Nutrition, Effects of Nutrition on Alcoholic Liver Disease, and Nutritional Therapies for Alcoholic Liver Disease. Clin Liver Dis (2016) 0.75
The Activation and Function of Autophagy in Alcoholic Liver Disease. Curr Mol Pharmacol (2017) 0.75
Sarcopenia in alcoholic liver disease: clinical and molecular advances. Alcohol Clin Exp Res (2017) 0.75
Hepato- and neuro-protective effects of watermelon juice on acute ethanol-induced oxidative stress in rats. Toxicol Rep (2016) 0.75
Etiology of alcoholic cardiomyopathy: mitochondria, oxidative stress and apoptosis. Int J Biochem Cell Biol (2017) 0.75
Caspase activation is required for terminal erythroid differentiation. J Exp Med (2001) 1.97
An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology (1999) 1.92
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther (1995) 1.78
Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology (1997) 1.61
Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology (1998) 1.58
Hepatitis after intravenous buprenorphine misuse in heroin addicts. J Hepatol (2001) 1.51
Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol (1996) 1.46
Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation. J Hepatol (2001) 1.44
The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab (2004) 1.43
Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. JAMA (1989) 1.38
Mitochondria in steatohepatitis. Semin Liver Dis (2001) 1.35
Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol (1990) 1.25
Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. Clin Res Hepatol Gastroenterol (2011) 1.25
Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol (1997) 1.18
Polymorphism of dextromethorphan oxidation in a French population. Br J Clin Pharmacol (1987) 1.17
Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol (1999) 1.16
Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol (1997) 1.16
Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf (1996) 1.16
[Hepatitis caused by diclofenac]. Gastroenterol Clin Biol (1983) 1.15
Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol (1999) 1.15
Acute and chronic drug-induced hepatitis. Baillieres Clin Gastroenterol (1988) 1.15
Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology (2001) 1.14
Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. Hepatology (2000) 1.13
Perhexiline maleate-induced cirrhosis. Gastroenterology (1979) 1.12
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. Biochem Pharmacol (1983) 1.11
Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. Gastroenterology (1993) 1.11
Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther (1990) 1.10
Mechanism for reduced drug clearance in patients with cirrhosis. Gastroenterology (1978) 1.10
Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatol (1997) 1.10
Amodiaquine-induced fulminant hepatitis. J Hepatol (1988) 1.05
Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes. J Pharmacol Exp Ther (1992) 1.04
Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis. J Clin Invest (1990) 1.04
Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses. Neurology (1998) 1.02
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. J Pharmacol Exp Ther (1989) 1.00
Pancreatic cholera. Sudies on tumoral secretions and pathophysiology of diarrhea. Gastroenterology (1975) 1.00
Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation. Am J Physiol (1997) 0.99
Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology (1995) 0.99
Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. J Pharmacol Exp Ther (1994) 0.99
Effect of surgery under general anaesthesia on antipyrine clearance. Br J Clin Pharmacol (1978) 0.98
Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol (1997) 0.98
Cross hepatotoxicity between tricyclic antidepressants. Gut (1986) 0.97
Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane. Hepatology (1990) 0.95
Pyrazinamide fulminant hepatitis: an old hepatotoxin strikes again. Lancet (1981) 0.95
Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions. Hepatology (1994) 0.95
Prolonged, but not acute, glutathione depletion promotes Fas-mediated mitochondrial permeability transition and apoptosis in mice. Hepatology (2001) 0.93
Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther (1990) 0.93
Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology (1977) 0.92
Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology (1997) 0.91
Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients. Br J Clin Pharmacol (1989) 0.91
Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol (2000) 0.90
Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes. Hepatology (2000) 0.90
Drug interactions and hepatitis produced by some macrolide antibiotics. J Antimicrob Chemother (1985) 0.90
Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther (1988) 0.90
Effects of macrolide antibiotics on drug metabolism in rats and in humans. Int J Clin Pharmacol Res (1983) 0.89
Peliosis hepatis induced by 6-thioguanine administration. Gut (1988) 0.88
Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450. Biochem Pharmacol (1981) 0.88
[Hepatitis caused by cyproheptadine (Periactine). A case and review of the literature]. Gastroenterol Clin Biol (1988) 0.88
Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding. Biochem Pharmacol (1987) 0.88
Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology (1995) 0.88
Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome. J Pharmacol Exp Ther (1991) 0.87
Metoprolol-induced hepatitis: rechallenge and drug oxidation phenotyping. Ann Intern Med (1988) 0.87
Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats. Biochem Pharmacol (1983) 0.87
Acute hepatitis caused by alverine associated with anti-lamin A and C autoantibodies. J Hepatol (1997) 0.87
Prolonged cholestasis after cyproheptadine-induced acute hepatitis. J Clin Gastroenterol (1987) 0.87
Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione. J Pharmacol Exp Ther (1983) 0.87
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology (1995) 0.86
Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology (1988) 0.86
Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans. Biochem Pharmacol (1982) 0.86
Beclin 1 mRNA strongly correlates with Bcl-XLmRNA expression in human hepatocellular carcinoma. Cancer Invest (2007) 0.85
Pirprofen-induced fulminant hepatitis. Gastroenterology (1985) 0.85
Autoantibodies against cytochromes P450: role in human diseases. Adv Pharmacol (1994) 0.85
Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy. Biochem Pharmacol (1999) 0.85
Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology (1979) 0.84
Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin. Dig Dis Sci (1994) 0.84
Protective effect of 16,16-dimethyl prostaglandin E2 on the hepatotoxicity of bromobenzene in mice. Biochem Pharmacol (1984) 0.84
Fulminant hepatitis after lisinopril administration. Gastroenterology (1990) 0.83
Effects of pregnancy on the toxicity and metabolism of acetaminophen in mice. J Pharmacol Exp Ther (1986) 0.83
Vesicular transport of newly synthesized cytochromes P4501A to the outside of rat hepatocyte plasma membranes. J Pharmacol Exp Ther (2000) 0.83
Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies. Mol Pharmacol (1994) 0.83
Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis. Br J Pharmacol (2012) 0.83
Hepatotoxicity of germander in mice. Gastroenterology (1994) 0.82
Uncoupling of rat and human mitochondria: a possible explanation for tacrine-induced liver dysfunction. Gastroenterology (1996) 0.82
Effects of various tetracycline derivatives on in vitro and in vivo beta-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. Biochem Pharmacol (1991) 0.82
Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: role of mitochondrial permeability transition and metabolic activation. J Pharmacol Exp Ther (2001) 0.82
Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. J Pharmacol Exp Ther (1981) 0.82
Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera. J Clin Invest (1996) 0.82